The environment for launching and commercialising Pharma brands is increasingly challenging, with new types of customers and stakeholders emerging, new requirements from Payers, new regulatory pathways, more competitive threats and a tough economic outlook.
To be ‘fit for purpose’ for today and tomorrow, a better approach to brand excellence is required which addresses how we identify, develop & communicate brand value with all the key stakeholders.
There are many options for addressing the challenges facing brand commercialisation. The question is, in the evolving environment of today and tomorrow, which solutions will really work, and which capabilities will we need to deliver these solutions?
GalbraithWight’s Brand Excellence is the first and only approach which has market access successfully embedded, and is truly cross- functional.
We deliver both a strategic and operational approach to Brand Excellence, from early phase brand positioning and life cycle management through customer engagement and communication, globally. We have a proven track record in creating some of the world’s most successful brands and building Brand Excellence capabilities in cross-functional teams in more than 70 countries.
Brand Excellence is built on the foundations of this successful experience, and represents future-proof world class best practice.
Our Brand Excellence work is real-world focused and future-proof. It includes advocacy from senior management, a robust brand planning framework, which is well understood and properly implemented cross-functionally
Critical analysis and the development of specific insights from customers (patients, healthcare professionals, payers, policy makers) and from competitors are the foundation on which to develop a successful brand plan
Brand Excellence needs to have a seamless technical execution through processes which make brand planning more effective
Brand Excellence requires growing capabilities at all levels. This involves defining competencies, training needs and implementation of personal development plans
As part of our Brand Excellence Execution Tools & Process, GalbraithWight is pleased to introduce our launch excellence panning application, Apollo LX. Apollo LX is the only Global Launch Excellence planning software with GalbraithWight's Market Access and Launch Planning expertise embedded in its platform.
Specifically designed for pharmaceutical, biotech and medical device companies, the core of Apollo LX is GalbraithWight's global launch planning insight and processes, delivered in an easy-to-use web application. Apollo LX provides launch strategy, communication, planning, tracking, clarity and control for ultimate launch success."